Stocktoria
GILEAD SCIENCES, INC. GILD
GILEAD SCIENCES, INC. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.4B | $28.8B | $27.1B | $27.3B | $27.3B | $24.7B | $22.4B | $22.1B | $26.1B | $30.4B |
| R&D expense | — | — | — | — | — | — | $9.1B | $5.0B | $3.7B | $5.1B |
| SG&A expense | $5.8B | $6.1B | $6.1B | $5.7B | $5.2B | $5.2B | $4.4B | $4.1B | $3.9B | $3.4B |
| Operating income | $10.0B | $1.7B | $7.6B | $7.3B | $9.9B | $4.1B | $4.3B | $8.2B | $14.1B | $17.6B |
| Interest expense | — | — | $944.0M | $935.0M | $1.0B | $984.0M | $995.0M | $1.1B | $1.1B | $964.0M |
| Income tax | $1.3B | $211.0M | $1.2B | $1.2B | $2.1B | $1.6B | -$204.0M | $2.3B | $8.9B | $3.6B |
| Net income | $8.5B | $480.0M | $5.7B | $4.6B | $6.2B | $123.0M | $5.4B | $5.5B | $4.6B | $13.5B |
| EPS (diluted) | $6.78 | $0.38 | $4.50 | $3.64 | $4.93 | $0.10 | $4.22 | $4.17 | $3.51 | $9.94 |
| Operating cash flow | $10.0B | $10.8B | $8.0B | $9.1B | $11.4B | $8.2B | $9.1B | $8.4B | $11.9B | $17.0B |
| Free cash flow | $9.5B | $10.3B | $7.4B | $8.3B | $10.8B | $7.5B | $8.3B | $7.5B | — | — |
| Cash & equivalents | — | — | — | $5.4B | $5.3B | $6.0B | $11.6B | $17.9B | $7.6B | $8.2B |
| Inventory | $1.8B | $1.7B | $1.8B | $1.5B | $1.6B | $1.7B | $922.0M | $814.0M | $801.0M | $1.6B |
| Total assets | $59.0B | $59.0B | $62.1B | $63.2B | $68.0B | $68.4B | $61.6B | $63.7B | $70.3B | $57.0B |
| Shareholders' equity | $22.7B | $19.3B | $22.8B | $21.2B | $21.1B | $18.2B | $22.6B | $21.5B | $20.5B | $19.4B |
Growth · year-over-year · Revenue CAGR -0.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +2.4% | +6.0% | -0.6% | -0.1% | +10.6% | +10.0% | +1.5% | -15.2% | -14.1% | -6.9% |
| Net income growth | +1672.9% | -91.5% | +23.4% | -26.2% | +4961.0% | -97.7% | -1.3% | +17.9% | -65.7% | -25.4% |
| EPS growth | +1684.2% | -91.6% | +23.6% | -26.2% | +4830.0% | -97.6% | +1.2% | +18.8% | -64.7% | -16.5% |
| Free cash flow growth | -8.2% | +38.9% | -11.1% | -22.8% | +43.7% | -9.6% | +11.3% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.